ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL
key details
| Status | complete |
|---|---|
| Region | Northern Ireland |
| Procedure | direct |
| OCID | ocds-h6vhtk-051a06 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| ALLOGA UK LIMITED | £750,000 | 20 May 2025 | active |
description
Procurement of ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 May 2025 | Transparency notice (UK5) | Procurement Act 2023 | 023655-2025 |
| 21 May 2025 | Contract award (UK6) | Procurement Act 2023 | 023668-2025 |
| 6 Jun 2025 | Contract details (UK7) | Procurement Act 2023 | 030614-2025 |
more from Belfast Health & Social Care Trust
- Life Support Training Course · £171,640 · 28 Jul 2026
- Surgical Dressings · £56,086,955 · 24 Jul 2026
- Mechanical Insufflation-Exsufflation, Associated Consumables and Ancillary Services · £3,839,792 · 21 Jul 2026
- ICPMS Analyser Service Maintenance · 9 Jul 2026
- Immunoglobulin Homecare (Human Normal) (Hizentra) · 8 Jul 2026
- Maintenance of Generator Sets including Alternators, Control Systems, Local and Remote ACB Switching Controls · £12,872,293 · 7 Jul 2026
- VORANIGO (VORASIDENIB TABLETS) · 7 Jul 2026
- OPDIVO (NIVOLUMAB) 600MG/5ML SOLUTION FOR INJECTION VIAL, 5 mL · 7 Jul 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.